Medicare Enrolled
Dr. Sean Warsch, M.D.
Hematology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Warsch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Warsch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Warsch
Dr. Sean Warsch is a hematology specialist in Asheville, NC, with 16 years of NPI registration. Based on federal Medicare data, Dr. Warsch performed 76,531 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Warsch received a total of $32,127 from 62 pharmaceutical and/or device companies across 310 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Warsch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 4% volume in NC
$32,127 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗76,531
Medicare services
Top 4% in NC for hematology
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 22,800 | $43 | $157 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,800 | $38 | $136 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $64 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
8,160 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 7,670 | $1 | $6 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,410 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,374 | $0 | $1 |
| Paclitaxel chemotherapy injection | 2,305 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,858 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,619 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,449 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,060 | $1 | $41 |
| Anti-nausea injection (ondansetron/Zofran) | 556 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
526 | $91 | $390 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
510 | $94 | $421 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
354 | $61 | $277 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
343 | $11 | $66 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 271 | $3 | $42 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
252 | $88 | $654 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
238 | $10 | $67 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
203 | $2 | $39 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
180 | $6 | $126 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
180 | $73 | $210 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
158 | $21 | $103 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
156 | $129 | $550 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $45 | $208 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
125 | $59 | $214 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
105 | $54 | $234 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
105 | $1 | $4 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $134 | $603 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
89 | $15 | $65 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
76 | $47 | $205 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $88 | $308 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
68 | $43 | $180 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
66 | $9 | $40 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
64 | $2 | $9 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
52 | $21 | $164 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
52 | $17 | $83 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
51 | $26 | $121 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $119 | $509 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
46 | $16 | $71 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
41 | $25 | $135 |
| New patient office visit, complex (60-74 min) | 40 | $166 | $673 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 36 | $196 | $1,533 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $94 | $406 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
30 | $59 | $313 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
25 | $1,082 | $4,447 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
25 | $3 | $11 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
25 | $1 | $22 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
24 | $51 | $375 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $24 | $105 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
20 | $174 | $746 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $132 | $595 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
17 | $95 | $404 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
15 | $3 | $13 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
13 | $1,089 | $4,472 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.1% high complexity
81.3% medium
6.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,127
Total received (2018-2024)
Avg $4,590/year across 7 years
Top 12% in NC for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
310
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,688
2023
$9,192
2022
$13,260
2021
$4,830
2020
$88
2019
$45
2018
$24
Payments by company (2024)
Karyopharm Therapeutics Inc.
$1,692
BeiGene USA, Inc.
$1,463
Novartis Pharmaceuticals Corporation
$235
Merck Sharp & Dohme LLC
$149
Celgene Corporation
$117
Janssen Biotech, Inc.
$97
E.R. Squibb & Sons, L.L.C.
$87
PFIZER INC.
$84
Astellas Pharma US Inc
$75
Janssen Pharmaceuticals, Inc
$64
Deciphera Pharmaceuticals Inc.
$48
Adaptive Biotechnologies Corporation
$47
AstraZeneca Pharmaceuticals LP
$44
SERVIER PHARMACEUTICALS LLC
$42
Takeda Pharmaceuticals U.S.A., Inc.
$42
SpringWorks Therapeutics, Inc.
$42
SOBI, INC
$41
Regeneron Healthcare Solutions, Inc.
$36
Pharmacosmos Therapeutics Inc.
$33
Gilead Sciences, Inc.
$28
ABBVIE INC.
$24
Kyowa Kirin, Inc.
$23
PharmaEssentia USA Corporation
$22
Spectrum Pharmaceuticals Inc.
$21
Agios Pharmaceuticals, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
PUMA BIOTECHNOLOGY, INC.
$19
Alexion Pharmaceuticals, Inc.
$18
Eisai Inc.
$16
Myriad Genetic Laboratories, Inc.
$16
Top 3 companies account for 72.3% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$16,450
GENZYME CORPORATION
$4,831
Karyopharm Therapeutics Inc.
$1,692
BeiGene USA, Inc.
$1,580
CTI BioPharma Corp.
$1,438
Daiichi Sankyo Inc.
$958
Novartis Pharmaceuticals Corporation
$640
Merck Sharp & Dohme LLC
$332
Janssen Biotech, Inc.
$301
E.R. Squibb & Sons, L.L.C.
$274
Celgene Corporation
$233
Amgen Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$189
Astellas Pharma US Inc
$182
Genentech USA, Inc.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
Merck Sharp & Dohme Corporation
$163
PFIZER INC.
$162
AstraZeneca Pharmaceuticals LP
$156
Stemline Therapeutics Inc.
$152
Seagen Inc.
$138
Alexion Pharmaceuticals, Inc.
$124
Gilead Sciences, Inc.
$117
Janssen Pharmaceuticals, Inc
$116
Mirati Therapeutics, Inc.
$114
Eisai Inc.
$82
EISAI INC.
$82
G1 Therapeutics, Inc.
$64
Tactile Systems Technology Inc
$53
Kyowa Kirin, Inc.
$52
Lilly USA, LLC
$50
PUMA BIOTECHNOLOGY, INC.
$49
Deciphera Pharmaceuticals Inc.
$48
Adaptive Biotechnologies Corporation
$47
PharmaEssentia USA Corporation
$46
SERVIER PHARMACEUTICALS LLC
$42
SpringWorks Therapeutics, Inc.
$42
SOBI, INC
$41
MorphoSys, US Inc.
$40
AVEO Pharmaceuticals, Inc.
$38
TerSera Therapeutics LLC
$37
GlaxoSmithKline, LLC.
$36
Pharmacosmos Therapeutics Inc.
$33
Foundation Medicine, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
ABBVIE INC.
$24
Taiho Oncology, Inc.
$24
AbbVie Inc.
$22
Spectrum Pharmaceuticals Inc.
$21
Agios Pharmaceuticals, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$19
Acrotech Biopharma LLC
$19
Medtronic, Inc.
$18
GE HealthCare
$18
Jazz Pharmaceuticals Inc.
$16
ARRAY BIOPHARMA INC
$16
Apellis Pharmaceuticals, Inc.
$16
Myriad Genetic Laboratories, Inc.
$16
Puma Biotechnology, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Incyte Corporation
$15
ADC Therapeutics America, Inc.
$13
Top 3 companies account for 71.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CALQUENCE · COSELA · CREON · CYRAMZA · DARZALEX · ELIQUIS · ERLEADA · EXKIVITY · Empaveli · Enhertu · FOTIVDA · Flexitouch Plus · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PADCEV · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · SANDOSTATIN · SCEMBLIX · SYNAGIS · TAGRISSO · TECVAYLI · TEVIMBRA · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vonjo · Vyloy · XARELTO · XPOVIO · XTANDI · Xospata · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
10
County median income
$70,578
Nearest hospital to ZIP centroid (approximate)
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Warsch is a mixed practice specialist, with above-average Medicare volume (top 4% in NC), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Warsch experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Warsch performed 22,800 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Warsch receive payments from pharmaceutical companies?
Yes. Dr. Warsch received a total of $32,127 from 62 companies across 310 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Warsch's costs compare to other hematologists in Asheville?
Dr. Warsch's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Warsch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Asheville
Browse hematologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NC
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NC
Which NC hematologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology